Bookmarks
Prescription of blood pressure lowering and lipid lowering treatment in the UK and New Zealand: a cross sectional study
Safe People
London School of Hygiene and Tropical Medicine
Academic Institute
Emily Herrett - Chief Investigator - London School of Hygiene & Tropical Medicine
Elizabeth Williamson - Collaborator - London School of Hygiene & Tropical Medicine
Helen Strongman - Collaborator - London School of Hygiene & Tropical Medicine
Krishnan Bhaskaran - Collaborator - London School of Hygiene & Tropical Medicine
Laurie Tomlinson - Collaborator - London School of Hygiene & Tropical Medicine
Liam Smeeth - Collaborator - London School of Hygiene & Tropical Medicine
Rod Jackson - Collaborator - University of Auckland
Sue Wells - Collaborator - University of Auckland
Safe Projects
CPRD02
The UK has well established guidelines for recommending statins and blood pressure lowering drugs to patients to reduce the risk of heart attacks and strokes. Statins are recommended to patients who are at high risk of heart attacks and strokes. Blood pressure lowering drugs are recommended based on both a patient’s blood pressure and their risk of heart attacks and strokes. GPs use the guideline recommendations, their own judgement, and discussions with the patient to decide on treatment. For example, when considering whether to prescribe blood pressure drugs, GPs will take into account not only the broad national guidelines but also (i) the risk of reducing blood pressure too much, which may lead to dizziness and falls, (ii) the risk of kidney disease, heart failure and stroke if a patient is not treated, and (iii) patient choice. Therefore, there are likely to be differences in the ways that the same patient would be treated across different GPs within the UK.
Background
10/06/2021
Safe Data
Patient Level Townsend Score
Safe Setting
Release